Science Quiz / Drugs MVST IB - part 1

Random Science Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

Forced Order
Challenge
Share
Tweet
Embed
Score 0/156 Timer 20:00
DescriptionDrug nameUse
Binds to neurexins, causing massive ACh release from nerve terminals
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
alpha-1 antagonist most commonly used
Glucocorticoid receptor antagonist
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Angiotensin II partial agonist
Combined alpha- and beta-adrenoceptor antagonist
Double chain recombinant human tissue plasminogen activator
Mineralocorticoid receptor agonist
Progestagen receptor antagonist
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
K channel opener - also NO donor
Orally-acting hypoglycaemic agent - sulphonylurea
Selective alpha-1 agonist (some action on beta-1)
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
K channel opener - also hirsutism effects
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Non-selective, reversible MAO inhibitor
Experimental cardiac glycoside
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
Mild partial beta-1 agonist
Acts on imidazoline receptors
Selective beta-2 antagonist (slight effect on beta-1)
Phosphodiesterase III inhibitor - inodilator
Selective alpha-2 antagonist (slight effect on alpha-1)
Binds to SNAREs involved in membrane fusion, preventing ACh release
Involved with providing new blood flow to ischaemic tissues
Estrogen receptor agonist
Phosphodiesterase III inhibitor - inodilator
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
Selective beta-1 antagonist (slight effect on beta-2)
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Cholinergic agonist - +-isomer hydrolysed by AChE
Selective antagonist for M3 muscarinic receptor
Tricyclic antidepressant - blocks NET
K channel opener
Reverse inhibition of AChE by organophosphorus agents
K channel opener
Immunosuppressant drug with antiproliferative effects
Selective inhibitor of NOS in neurons
Acts on imidazoline receptors
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
Depolarising blocker at NMJ
Blocks uptake of choline into neurons
Very potent alpha-2 agonist
Binds to plasminogen activator, increasing generation of plasmin
Local anaesthetic - uncharged
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
DescriptionDrug nameUse
Muscarinic receptor antagonist - very long duration of action
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Reversible anticholinesterase - ionic interaction
Nitrovasodilator - produces NO - metabolised in liver to active drug
Selective MAO-B inhibitor
Irreversible anticholinesterase - organophosphorus agent
Depolarising blocker selective for ganglion nicotinic receptor
Illegal drug - blocks NET
Class IC antidysrhythmic
Blocks transporter carrying ACh into storage vesicles
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
Selective MAO-A inhibitor
Osmotic diuretic - filtered at glomerulus, not reabsorbed
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
SSRI - blocks 5-HT transporter in Uptake 1
Non-selective agonist for muscarinic receptors
Plasminogen + anisoylated streptokinase
Selective beta-2 agonist (slight effect on beta-1)
Inhibits DOPA decarboxylase in periphery
Use-dependent block of ganglionic transmission
NOS inhibitor - not very selective for different forms
Estrogen receptor antagonist
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
Beta-1 agonist - weak beta-2 agonist
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Anion exchange resin - prevents reuptake of bile acids from intestine
Non-specific endothelin receptor antagonist
Glucocorticoid receptor agonist
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Orally-acting hypoglycaemic agent - sulphonylurea
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
Interferes with normal function of microtubule growth
Calcium channel agonist - dihydropyridine
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Tricyclic antidepressant - blocks NET
Calcium channel blocker - benzothiazepine
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
Non-selective phosphodiesterase inhibitor
Carbonic anhydrase inhibitor
Irreversibly alkylates muscarinic receptor
Beta-1 antagonist used in heart failure
PPAR-gamma agonist
Tyrosine kinase inhibitor
Blocks Na channels from exterior - no use-dependence
Muscarinic receptor agonist
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
Regulates expression of multiple angiogenic genes
DescriptionDrug nameUse
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
Nitrovasodilator - produces NO
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
Arteriolar vasodilator - unknown mechanism
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
A1 receptor antagonist - non-selective phosphodiesterase inhibitor
ACE inhibitor
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
Causes development of new blood vessels
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Selective alpha-2 agonist
Non-selective agonist for muscarnic receptors
COMT inhibitor
ACE inhibitor - prodrug, must be metabolised in liver
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Non-selective phosphodiesterase inhibitor
Alpha-2 antagonist (some effect on alpha-1)
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
Selective alpha-1 antagonist (slight effect on alpha-2)
Class III antidysrhythmic - prolongs AP and refractory period
Non-peptide angiotensin II antagonist - acts on AT1 receptors
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Progestagen receptor agonist
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
Local anaesthetic (ester, weak base) - broken down by BuChE
NSAID used to prevent thrombosis
Cardiac glycoside - inhibits Na/K-ATPase
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Non-selective alpha-adrenoceptor antagonist
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
Non-selective beta-adrenoceptor antagonist
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Selective antagonist for M1 muscarinic receptors
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
Beta-adrenoceptor agonist
Beta-1 antagonist used in heart failure
Blocks If current in SA node
Direct acting vasodilator - metabolised to NO or cyanide
Nitrovasodilator - produces NO - taken sublingually
Potent, irreversible inhibitor of iNOS in activated macrophages
Inhibits HMG-CoA reductase - also many pleiotropic effects
Competitive inhibitor of tyrosine hydroxylase
Local anaesthetic - weak base - use-dependence and voltage-dependence
Single chain recombinant human tissue plasminogen activator

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras

Top Quizzes Today


Score Distribution

Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.